SCHEMBL20148732

SCHEMBL20148732

CC(C)Oc1ccc(C(=O)N2C3CC2CN(C(C)C)C3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
PARP10 Q53GL7 1/20 0.46
ALDH1A1 P00352 5/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 5/20 0.41
TP53 P04637 3/20 0.41
HTT P42858 2/20 0.41
THRB P10828 1/20 0.41
RET P07949 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
USP2 O75604 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20071116 0.91 ALDH1A1 (0.47) KMT2APARP10ALDH1A1LMNATSHR
SCHEMBL22030865 0.87 KMT2A (0.49) KMT2APARP10ALDH1A1HPGDLMNA
SCHEMBL20154583 0.87 MAPT (0.43) KMT2APARP10ALDH1A1HPGDLMNA
SCHEMBL20153229 0.84 KMT2A (0.40) KMT2APARP10ALDH1A1HPGDLMNA
SCHEMBL20152354 0.84 KMT2A (0.45) KMT2APARP10ALDH1A1HPGDLMNA
SCHEMBL20071117 0.82 KMT2A (0.49) KMT2APARP10ALDH1A1HPGDLMNA
SCHEMBL22030863 0.79 ALDH1A1 (0.46) KMT2AALDH1A1TSHRHTTRET
SCHEMBL22030862 0.77 ALDH1A1 (0.49) KMT2AALDH1A1LMNATSHRNPC1
SCHEMBL20148711 0.76 HDAC1 (0.40) KMT2AALDH1A1LMNARETMEN1
SCHEMBL20148701 0.76 HRH3 (0.38) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066029-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2024-02-29 US disclosed
US-20210186959-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA, INC. 2021-06-24 US disclosed
EP-3753939-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS Array Biopharma Inc. (US) 2020-12-23 EP disclosed
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed
US-20180133200-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180133200-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF KMT2A 1171/4885PARP10 1943/4885ALDH1A1 2868/4885
US-20210186959-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF KMT2A 1171/4885PARP10 1943/4885ALDH1A1 2868/4885
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF KMT2A 1171/4885PARP10 1943/4885ALDH1A1 2868/4885
US-20240066029-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF KMT2A 1171/4885PARP10 1943/4885ALDH1A1 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.